GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
In September last year, the US Food and Drug Administration approved Ojjaara for the same indication. Initially developed by ...
A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
While generics may dominate due to cost advantages and meeting needs of a developing economy, there is a growing thrust ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...
The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...
The National on MSN5d
Will we ever see an end to animal testing?Animal testing remains widespread, but the long history of campaigning against it has made some inroads, with some sectors pioneering alternative methods and scientists highlighting its shortcomings.A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback